<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>systems biology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>systems biology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Systematic exploration of prokaryotic form I rubisco maximal carboxylation rates
Authors: de Pins, B.; Greenspoon, L.; Bar-On, Y. M.; Shamshoum, M.; Ben-Nissan, R.; Milshtein, E.; Davidi, D.; Sharon, I.; Mueller-Cajar, O.; Noor, E.; Milo, R.
Score: 19.3, Published: 2023-07-27 DOI: 10.1101/2023.07.27.550689
Autotrophy is the basis for complex life on Earth. Its physiological limits are largely constrained by rubisco - the enzyme that catalyzes almost all carbon fixation on the planet.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/systems-biology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="systems biology" />
<meta property="og:description" content="Systematic exploration of prokaryotic form I rubisco maximal carboxylation rates
Authors: de Pins, B.; Greenspoon, L.; Bar-On, Y. M.; Shamshoum, M.; Ben-Nissan, R.; Milshtein, E.; Davidi, D.; Sharon, I.; Mueller-Cajar, O.; Noor, E.; Milo, R.
Score: 19.3, Published: 2023-07-27 DOI: 10.1101/2023.07.27.550689
Autotrophy is the basis for complex life on Earth. Its physiological limits are largely constrained by rubisco - the enzyme that catalyzes almost all carbon fixation on the planet." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/systems-biology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-08-09T10:39:33+00:00" />
<meta property="article:modified_time" content="2023-08-09T10:39:33+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="systems biology"/>
<meta name="twitter:description" content="Systematic exploration of prokaryotic form I rubisco maximal carboxylation rates
Authors: de Pins, B.; Greenspoon, L.; Bar-On, Y. M.; Shamshoum, M.; Ben-Nissan, R.; Milshtein, E.; Davidi, D.; Sharon, I.; Mueller-Cajar, O.; Noor, E.; Milo, R.
Score: 19.3, Published: 2023-07-27 DOI: 10.1101/2023.07.27.550689
Autotrophy is the basis for complex life on Earth. Its physiological limits are largely constrained by rubisco - the enzyme that catalyzes almost all carbon fixation on the planet."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "systems biology",
      "item": "https://trxiv.yorks0n.com/posts/systems-biology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "systems biology",
  "name": "systems biology",
  "description": "Systematic exploration of prokaryotic form I rubisco maximal carboxylation rates\nAuthors: de Pins, B.; Greenspoon, L.; Bar-On, Y. M.; Shamshoum, M.; Ben-Nissan, R.; Milshtein, E.; Davidi, D.; Sharon, I.; Mueller-Cajar, O.; Noor, E.; Milo, R.\nScore: 19.3, Published: 2023-07-27 DOI: 10.1101/2023.07.27.550689\nAutotrophy is the basis for complex life on Earth. Its physiological limits are largely constrained by rubisco - the enzyme that catalyzes almost all carbon fixation on the planet.",
  "keywords": [
    
  ],
  "articleBody": " Systematic exploration of prokaryotic form I rubisco maximal carboxylation rates\nAuthors: de Pins, B.; Greenspoon, L.; Bar-On, Y. M.; Shamshoum, M.; Ben-Nissan, R.; Milshtein, E.; Davidi, D.; Sharon, I.; Mueller-Cajar, O.; Noor, E.; Milo, R.\nScore: 19.3, Published: 2023-07-27 DOI: 10.1101/2023.07.27.550689\nAutotrophy is the basis for complex life on Earth. Its physiological limits are largely constrained by rubisco - the enzyme that catalyzes almost all carbon fixation on the planet. Yet, with only a small fraction of rubisco diversity kinetically characterized so far, the underlying biological factors driving the evolution of fast rubiscos in nature remain unclear. We conducted a high-throughput kinetic characterization of over 100 prokaryotic form I rubiscos, the most ubiquitous group of rubisco sequences in nature, to uncover the determinants of rubiscos carboxylation velocity. We show that phototrophy and the presence of a carboxysome CO2 concentrating mechanism correlate with faster rubiscos (median rate difference of 3-5 fold). In contrast to previous assumptions, rubiscos originating from -cyanobacteria exhibit the highest carboxylation rates among form I enzymes ({approx}10 s-1 median versus \u003c7 s-1 in other groups). Our study ties biological and environmental insights associated with kinetic variation across rubiscos from nature.\nPathogenic mutations of human phosphorylation sites affect protein-protein interactions\nAuthors: Rrustemi, T.; Meyer, K.; Roske, Y.; Uyar, B.; Akalin, A.; Imami, K.; Ishihama, Y.; Daumke, O.; Selbach, M.\nScore: 8.2, Published: 2023-08-03 DOI: 10.1101/2023.08.01.551433\nDespite their lack of a defined 3D structure, intrinsically disordered regions (IDRs) of proteins play important biological roles. Many IDRs contain short linear motifs (SLiMs) that mediate protein-protein interactions (PPIs), which can be regulated by post-translational modifications like phosphorylation. 20% of pathogenic missense mutations are found in IDRs, and understanding how such mutations affect PPIs is essential for unraveling disease mechanisms. Here, we employed peptide-based interaction proteomics to investigate 36 disease-causing mutations affecting phosphorylation sites. Our results unveiled significant differences in interactomes between phosphorylated and non-phosphorylated peptides, often due to disrupted phosphorylation-dependent SLiMs. We focused on a mutation of a serine phosphorylation site in the transcription factor GATAD1, which causes dilated cardiomyopathy. We found that this phosphorylation site mediates interaction with 14-3-3 family proteins. Follow-up experiments revealed the structural basis of this interaction and suggest that 14-3-3 binding affects GATAD1 nucleocytoplasmic transport by masking a nuclear localisation signal. Our results demonstrate that pathogenic mutations of human phosphorylation sites can significantly impact protein-protein interactions, offering fresh insights into potential molecular mechanisms underlying pathogenesis.\nAutomatic design of gene regulatory mechanisms for spatial pattern formation\nAuthors: Mousavi, R.; Lobo, D.\nScore: 4.5, Published: 2023-07-29 DOI: 10.1101/2023.07.26.550573\nGene regulatory mechanisms (GRMs) control the formation of spatial and temporal expression patterns that can serve as regulatory signals for the development of complex shapes. Synthetic developmental biology aims to engineer such mechanisms for understanding and producing desired multicellular patterns. However, the design of synthetic GRMs that can produce a target spatial gene expression pattern is a current challenge due to the nonlinear interactions and feedback loops present in genetic circuits. Here we present a methodology to automatically design GRMs that can produce any given spatial pattern. The proposed approach uses two orthogonal morphogen gradients acting as positional information signals in a multicellular tissue area or culture, which constitutes a continuous field of engineered cells implementing the same designed GRM. To efficiently design both the circuit network and the interaction mechanisms--including the number of genes required for the formation of the target pattern--we developed an automated algorithm based on high-performance evolutionary computation. The tolerance of the algorithm can be configured to design GRMs that are either simple to produce approximate patterns or complex to produce precise patterns. We demonstrate its performance by automatically designing GRMs for a diverse set of synthetic spatial expression patterns. The proposed method offers a versatile approach to systematically design and discover pattern-producing genetic circuits.\nDensity Physics-Informed Neural Network reveals sources of cell heterogeneity in signal transduction\nAuthors: Jo, H.; Hong, H.; Hwang, H. J.; Chang, W.; Kim, J. K.\nScore: 3.6, Published: 2023-08-02 DOI: 10.1101/2023.07.31.551393\nThe transduction time between signal initiation and final response provides valuable information on the underlying signaling pathway, including its speed and precision. Furthermore, multimodality in transduction-time distribution informs that the response is regulated by multiple pathways with different transduction speeds. Here, we developed Density physics-informed neural network (Density-PINN) to infer the transduction-time distribution, challenging to measure, from measurable final stress response time traces. We applied Density-PINN to single-cell gene expression data from 16 promoters regulated by unknown pathways in response to antibiotic stresses. We found that promoters with slower signaling initiation and transduction exhibit larger cell-to-cell heterogeneity in response intensity. However, this heterogeneity was greatly reduced when the response was regulated by slow and fast pathways together. This suggests a strategy for identifying effective signaling pathways for consistent cellular responses to disease treatments. Density-PINN can also be applied to understand various time delay systems, including infectious diseases.\nSystems Age: A single blood methylation test to quantify aging heterogeneity across 11 physiological systems\nAuthors: Sehgal, R.; Meer, M.; Shadyab, A. H.; Casanova, R.; Manson, J. E.; Bhatti, P.; Crimmins, E. M.; Assimes, T. L.; Whitsel, E. A.; Higgins-Chen, A. T.; Levine, M.\nScore: 42.9, Published: 2023-07-17 DOI: 10.1101/2023.07.13.548904\nIndividuals, organs, tissues, and cells age in diverse ways throughout the lifespan. Epigenetic clocks attempt to quantify differential aging between individuals, but they typically summarize aging as a single measure, ignoring within-person heterogeneity. Our aim was to develop novel systems-based methylation clocks that, when assessed in blood, capture aging in distinct physiological systems. We combined supervised and unsupervised machine learning methods to link DNA methylation, system-specific clinical chemistry and functional measures, and mortality risk. This yielded a panel of 11 system-specific scores- Heart, Lung, Kidney, Liver, Brain, Immune, Inflammatory, Blood, Musculoskeletal, Hormone, and Metabolic. Each system score predicted a wide variety of outcomes, aging phenotypes, and conditions specific to the respective system, and often did so more strongly than existing epigenetic clocks that report single global measures. We also combined the system scores into a composite Systems Age clock that is predictive of aging across physiological systems in an unbiased manner. Finally, we showed that the system scores clustered individuals into unique aging subtypes that had different patterns of age-related disease and decline. Overall, our biological systems based epigenetic framework captures aging in multiple physiological systems using a single blood draw and assay and may inform the development of more personalized clinical approaches for improving age-related quality of life.\nInterpreting roles of mutations associated with the emergence of S. aureus USA300 strains using transcriptional regulatory network reconstruction\nAuthors: Poudel, S.; Hyun, J. C.; Hefner, Y.; Monk, J.; Nizet, V.; Palsson, B. O.\nScore: 3.1, Published: 2023-07-29 DOI: 10.1101/2023.07.26.550757\nThe Staphylococcus aureus clonal complex 8 (CC8) is made up of several subtypes with varying levels of clinical burden; from community-associated methicillin resistant S. aureus (CA-MRSA) USA300 strains to hospital-associated (HA-MRSA) USA500 strains and basal methicillin susceptible (MSSA) strains. This phenotypic distribution within a single clonal complex makes CC8 an ideal clade to study the emergence of mutations important for antibiotic resistance and community spread. Gene level analysis comparing USA300 against MSSA and HA-MRSA strains have revealed key horizontally acquired genes important for its rapid spread in the community. However, efforts to define the contributions of point mutations and indels have been confounded by strong linkage disequilibrium resulting from clonal propagation. To break down this confounding effect, we combined genetic association testing with a model of the transcriptional regulatory network (TRN) to find candidate mutations that may have led to changes in gene regulation. First, we used a De Bruijn graph genome-wide association study (DBGWAS) to enrich mutations unique to the USA300 lineages within CC8. Next, we reconstructed the TRN by using Independent Component Analysis on 670 RNA sequencing samples from USA300 and non-USA300 CC8 strains which predicted several genes with strain-specific altered expression patterns. Examination of the regulatory region of one of the genes enriched by both approaches, isdH, revealed a 38 base pair deletion containing a Fur binding site and a conserved SNP which likely led to the altered expression levels in USA300 strains. Taken together, our results demonstrate the utility of reconstructed TRNs to address the limits of genetic approaches when studying emerging pathogenic strains.\nQuantifying mutational synergy using computational models predicts survival in haematological cancers\nAuthors: Norris, R.; Jones, J.; Mancini, E.; Chevassut, T.; Pepper, C.; Pepper, A.; Mitchell, S.\nScore: 5.9, Published: 2023-07-11 DOI: 10.1101/2023.07.10.548371\nGenetic heterogeneity and co-occurring driver mutations contribute to poor clinical outcomes in cancer. However, the impact of multiple mutations on complex signalling networks is not easily predicted. We found that, by placing mutations into their cellular context, multi-scale agent- based mathematical models could predict how genetic events combine in haematological malignancies. Simulations of lymphoma and myeloma predicted co-occurring mutations synergised to increase tumour cell expansion beyond what would be expected from the impact of the individual mutations alone. Mutational synergy between MYC and BCL2 was consistent with the more aggressive disease course of patients with double-hit lymphoma, and mutational synergy between MCL1 and CKS1B was predictive of outcome in patients with gain 1q multiple myeloma. Incorporating patient-specific mutational profiles into personalised models of lymphoma patients with the worst clinical outcomes revealed a correlation between simulated mutational synergy and overall survival, which outperformed widely used classifications of lymphoma informed by gene expression or mutational data alone. Our results demonstrated that mutational synergy scores enabled prediction of the impact of co-occurring mutations and may improve personalised prognostic predictions.\nEvaluation of Fendiline Treatment in VP40 System with Nucleation-Elongation Process: A Computational Model of Ebola Virus Matrix Protein Assembly\nAuthors: Liu, X.; Husby, M.; Stahelin, R. V.; Pienaar, E.\nScore: 1.2, Published: 2023-08-03 DOI: 10.1101/2023.08.03.551833\nEbola virus (EBOV) infection is threatening human health, especially in Central and West Africa. Limited clinical trials and the requirement of biosafety level-4 (BSL-4) laboratories hinders experimental work to advance our understanding of EBOV and evaluation of treatment. In this work, we use a computational model to study the assembly and budding process of EBOV and evaluate the effect of fendiline on these processes. Our results indicate that the assembly of VP40 filaments may follow the nucleation-elongation theory, as it is critical to maintain a pool of VP40 dimer for the maturation and production of virus-like particles (VLPs). We further find that the nucleation-elongation process can also be influenced by phosphatidylserine (PS), which can complicate the efficacy of fendiline, a drug that lowers cellular PS levels. We observe that fendiline may increase VLP production at earlier time points (24 h) and under low concentrations ([\u0026le;] 2 M). But this effect is transient and does not change the conclusion that fendiline generally decreases VLP production. We also conclude that fendiline can be more efficient at the stage of VLP budding relative to earlier phases. Combination therapy with a VLP budding step-targeted drug may further increase the treatment efficiency of fendiline. Finally, we also show that fendiline has higher efficacy when VP40 expression is high. While these are single-cell level results based on the VP40 system, it points out a potential way of fendiline application affecting EBOV assembly, which can be further tested in experimental studies with multiple EBOV proteins or live virus. ImportanceEBOV infection can cause deadly hemorrhagic fever, which has a mortality rate around 90% without treatment. The recent outbreaks in Uganda and Democratic Republic of the Congo illustrate its treat to human health. Though two antibody-based treatments are approved, mortality rates in the last outbreak is still higher than 30%. This can partly be due to the requirement of advanced medical facilities for current treatments. As a result, it is very important to develop and evaluate new therapies for EBOV infection, especially those can be easily applied in the developing world. The significance of our research is that we evaluate the potential treatment effect of fendiline on EBOV infection in the VP40 system with a computational approach, which both greatly saves time and lowers cost compared to traditional experimental studies, and provides innovative new tools to study viral protein dynamics.\nIdentifying repurposed drugs with moderate anti-influenza virus activity through computational prioritization of drug-target pairs\nAuthors: Taye, B.; Thuenauer, R.; Sugrue, R. J.; Maurer-Stroh, S.; Kosinski, J.\nScore: 1.2, Published: 2023-08-02 DOI: 10.1101/2023.07.31.551116\nInfluenza A virus (IAV) causes up to five million cases of severe illness and half a million deaths worldwide each year. While there are a few clinically approved drugs for treating IAV, they are challenged by the rapid evolution of the virus leading to emergence of drug resistance and the adverse effects of the drugs. Targeting host cellular factors that support virus replication could limit resistance, increase the broad-spectrum antiviral properties of drugs, and benefit from repurposing drugs already existing against those factors. However, selecting the right drug-target pairs with low toxicity and minimal adverse effects has been challenging, even though hundreds of cellular host factors have been identified. In this study, we applied a computational and knowledge-based drug-target prioritization approach to identify promising drug-target pairs. We selected five pairs for experimental validation: telmisartan-Angiotensin II receptor, type 1 (AGTR1), metoclopramide hydrochloride-Cholinergic receptor muscarinic 1 (CHRM1), cefepime hydrochloride-phosphogluconate dehydrogenase (PGD), ranolazine dihydrochloride-sodium channel voltage-gated type v alpha subunit (SCN5A), and ofloxacin-topoisomerase II alpha 170kDa (TOP2A). Except for cefepime hydrochloride, all four drugs showed significant plaque reduction in Madin Darby canine kidney (MDCK) cells. In the immunofluorescence assay, metoclopramide hydrochloride, ranolazine dihydrochloride, and telmisartan showed antiviral activity in MDCK and/or adenocarcinoma human alveolar basal epithelial (A549) cell lines. In conclusion, our approach can prioritize and identify drugs with antiviral activity against influenza virus. Refining and strengthening such approaches could be valuable for rapid antiviral discovery and pandemic preparedness. HighlightsO_LIComputational drug-target prioritization indicated drugs for validation C_LIO_LITelmisartan showed anti-influenza virus activity in MDCK cells C_LIO_LIMetoclopramide and ranolazine showed anti-influenza activity in A549 and MDCK cells C_LI\nProstate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes\nAuthors: Khoo, A.; Govindarajan, M.; Qui, Z.; Liu, L. Y.; Ignatchenko, V.; Waas, M.; Macklin, A.; Keszei, A.; Main, B. P.; Yang, L.; Lance, R. S.; Downes, M. R.; Semmes, O. J.; Vesprini, D.; Liu, S. K.; Nyalwidhe, J. O.; Boutros, P. C.; Kislinger, T.\nScore: 9.5, Published: 2023-07-25 DOI: 10.1101/2023.07.23.550214\nUrine is a complex biofluid that reflects both overall physiologic state and the state of the genitourinary tissues through which it passes. It contains both secreted proteins and proteins encapsulated in tissue-derived extracellular vesicles (EVs). To understand the population variability and clinical utility of urine, we quantified the secreted and EV proteomes from 190 men, including a subset with prostate cancer. We demonstrate that a simple protocol enriches prostatic proteins in urine. Secreted and EV proteins arise from different subcellular compartments. Urinary EVs are faithful surrogates of tissue proteomes, but secreted proteins in urine or cell line EVs are not. The urinary proteome is longitudinally stable over several years. It can accurately and non-invasively distinguish malignant from benign prostatic lesions, and can risk-stratify prostate tumors. This resource quantifies the complexity of the urinary proteome, and reveals the synergistic value of secreted and EV proteomes for translational and biomarker studies.\n",
  "wordCount" : "2501",
  "inLanguage": "en",
  "datePublished": "2023-08-09T10:39:33Z",
  "dateModified": "2023-08-09T10:39:33Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/systems-biology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      systems biology
    </h1>
    <div class="post-meta"><span>updated on August 9, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.27.550689">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.27.550689" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.27.550689">
        <p class="paperTitle">Systematic exploration of prokaryotic form I rubisco maximal carboxylation rates</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.27.550689" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.27.550689" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: de Pins, B.; Greenspoon, L.; Bar-On, Y. M.; Shamshoum, M.; Ben-Nissan, R.; Milshtein, E.; Davidi, D.; Sharon, I.; Mueller-Cajar, O.; Noor, E.; Milo, R.</p>
        <p class="info">Score: 19.3, Published: 2023-07-27 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.27.550689' target='https://doi.org/10.1101/2023.07.27.550689'> 10.1101/2023.07.27.550689</a></p>
        <p class="abstract">Autotrophy is the basis for complex life on Earth. Its physiological limits are largely constrained by rubisco - the enzyme that catalyzes almost all carbon fixation on the planet. Yet, with only a small fraction of rubisco diversity kinetically characterized so far, the underlying biological factors driving the evolution of fast rubiscos in nature remain unclear. We conducted a high-throughput kinetic characterization of over 100 prokaryotic form I rubiscos, the most ubiquitous group of rubisco sequences in nature, to uncover the determinants of rubiscos carboxylation velocity. We show that phototrophy and the presence of a carboxysome CO2 concentrating mechanism correlate with faster rubiscos (median rate difference of 3-5 fold). In contrast to previous assumptions, rubiscos originating from -cyanobacteria exhibit the highest carboxylation rates among form I enzymes ({approx}10 s-1 median versus &lt;7 s-1 in other groups). Our study ties biological and environmental insights associated with kinetic variation across rubiscos from nature.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.01.551433">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.01.551433" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.01.551433">
        <p class="paperTitle">Pathogenic mutations of human phosphorylation sites affect protein-protein interactions</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.01.551433" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.01.551433" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Rrustemi, T.; Meyer, K.; Roske, Y.; Uyar, B.; Akalin, A.; Imami, K.; Ishihama, Y.; Daumke, O.; Selbach, M.</p>
        <p class="info">Score: 8.2, Published: 2023-08-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.01.551433' target='https://doi.org/10.1101/2023.08.01.551433'> 10.1101/2023.08.01.551433</a></p>
        <p class="abstract">Despite their lack of a defined 3D structure, intrinsically disordered regions (IDRs) of proteins play important biological roles. Many IDRs contain short linear motifs (SLiMs) that mediate protein-protein interactions (PPIs), which can be regulated by post-translational modifications like phosphorylation. 20% of pathogenic missense mutations are found in IDRs, and understanding how such mutations affect PPIs is essential for unraveling disease mechanisms. Here, we employed peptide-based interaction proteomics to investigate 36 disease-causing mutations affecting phosphorylation sites. Our results unveiled significant differences in interactomes between phosphorylated and non-phosphorylated peptides, often due to disrupted phosphorylation-dependent SLiMs. We focused on a mutation of a serine phosphorylation site in the transcription factor GATAD1, which causes dilated cardiomyopathy. We found that this phosphorylation site mediates interaction with 14-3-3 family proteins. Follow-up experiments revealed the structural basis of this interaction and suggest that 14-3-3 binding affects GATAD1 nucleocytoplasmic transport by masking a nuclear localisation signal. Our results demonstrate that pathogenic mutations of human phosphorylation sites can significantly impact protein-protein interactions, offering fresh insights into potential molecular mechanisms underlying pathogenesis.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.26.550573">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.26.550573" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.26.550573">
        <p class="paperTitle">Automatic design of gene regulatory mechanisms for spatial pattern formation</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.26.550573" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.26.550573" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Mousavi, R.; Lobo, D.</p>
        <p class="info">Score: 4.5, Published: 2023-07-29 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.26.550573' target='https://doi.org/10.1101/2023.07.26.550573'> 10.1101/2023.07.26.550573</a></p>
        <p class="abstract">Gene regulatory mechanisms (GRMs) control the formation of spatial and temporal expression patterns that can serve as regulatory signals for the development of complex shapes. Synthetic developmental biology aims to engineer such mechanisms for understanding and producing desired multicellular patterns. However, the design of synthetic GRMs that can produce a target spatial gene expression pattern is a current challenge due to the nonlinear interactions and feedback loops present in genetic circuits. Here we present a methodology to automatically design GRMs that can produce any given spatial pattern. The proposed approach uses two orthogonal morphogen gradients acting as positional information signals in a multicellular tissue area or culture, which constitutes a continuous field of engineered cells implementing the same designed GRM. To efficiently design both the circuit network and the interaction mechanisms--including the number of genes required for the formation of the target pattern--we developed an automated algorithm based on high-performance evolutionary computation. The tolerance of the algorithm can be configured to design GRMs that are either simple to produce approximate patterns or complex to produce precise patterns. We demonstrate its performance by automatically designing GRMs for a diverse set of synthetic spatial expression patterns. The proposed method offers a versatile approach to systematically design and discover pattern-producing genetic circuits.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.31.551393">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.31.551393" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.31.551393">
        <p class="paperTitle">Density Physics-Informed Neural Network reveals sources of cell heterogeneity in signal transduction</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.31.551393" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.31.551393" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Jo, H.; Hong, H.; Hwang, H. J.; Chang, W.; Kim, J. K.</p>
        <p class="info">Score: 3.6, Published: 2023-08-02 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.31.551393' target='https://doi.org/10.1101/2023.07.31.551393'> 10.1101/2023.07.31.551393</a></p>
        <p class="abstract">The transduction time between signal initiation and final response provides valuable information on the underlying signaling pathway, including its speed and precision. Furthermore, multimodality in transduction-time distribution informs that the response is regulated by multiple pathways with different transduction speeds. Here, we developed Density physics-informed neural network (Density-PINN) to infer the transduction-time distribution, challenging to measure, from measurable final stress response time traces. We applied Density-PINN to single-cell gene expression data from 16 promoters regulated by unknown pathways in response to antibiotic stresses. We found that promoters with slower signaling initiation and transduction exhibit larger cell-to-cell heterogeneity in response intensity. However, this heterogeneity was greatly reduced when the response was regulated by slow and fast pathways together. This suggests a strategy for identifying effective signaling pathways for consistent cellular responses to disease treatments. Density-PINN can also be applied to understand various time delay systems, including infectious diseases.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.13.548904">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.13.548904" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.13.548904">
        <p class="paperTitle">Systems Age: A single blood methylation test to quantify aging heterogeneity across 11 physiological systems</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.13.548904" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.13.548904" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Sehgal, R.; Meer, M.; Shadyab, A. H.; Casanova, R.; Manson, J. E.; Bhatti, P.; Crimmins, E. M.; Assimes, T. L.; Whitsel, E. A.; Higgins-Chen, A. T.; Levine, M.</p>
        <p class="info">Score: 42.9, Published: 2023-07-17 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.13.548904' target='https://doi.org/10.1101/2023.07.13.548904'> 10.1101/2023.07.13.548904</a></p>
        <p class="abstract">Individuals, organs, tissues, and cells age in diverse ways throughout the lifespan. Epigenetic clocks attempt to quantify differential aging between individuals, but they typically summarize aging as a single measure, ignoring within-person heterogeneity. Our aim was to develop novel systems-based methylation clocks that, when assessed in blood, capture aging in distinct physiological systems. We combined supervised and unsupervised machine learning methods to link DNA methylation, system-specific clinical chemistry and functional measures, and mortality risk. This yielded a panel of 11 system-specific scores- Heart, Lung, Kidney, Liver, Brain, Immune, Inflammatory, Blood, Musculoskeletal, Hormone, and Metabolic. Each system score predicted a wide variety of outcomes, aging phenotypes, and conditions specific to the respective system, and often did so more strongly than existing epigenetic clocks that report single global measures. We also combined the system scores into a composite Systems Age clock that is predictive of aging across physiological systems in an unbiased manner. Finally, we showed that the system scores clustered individuals into unique aging subtypes that had different patterns of age-related disease and decline. Overall, our biological systems based epigenetic framework captures aging in multiple physiological systems using a single blood draw and assay and may inform the development of more personalized clinical approaches for improving age-related quality of life.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.26.550757">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.26.550757" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.26.550757">
        <p class="paperTitle">Interpreting roles of mutations associated with the emergence of S. aureus USA300 strains using transcriptional regulatory network reconstruction</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.26.550757" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.26.550757" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Poudel, S.; Hyun, J. C.; Hefner, Y.; Monk, J.; Nizet, V.; Palsson, B. O.</p>
        <p class="info">Score: 3.1, Published: 2023-07-29 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.26.550757' target='https://doi.org/10.1101/2023.07.26.550757'> 10.1101/2023.07.26.550757</a></p>
        <p class="abstract">The Staphylococcus aureus clonal complex 8 (CC8) is made up of several subtypes with varying levels of clinical burden; from community-associated methicillin resistant S. aureus (CA-MRSA) USA300 strains to hospital-associated (HA-MRSA) USA500 strains and basal methicillin susceptible (MSSA) strains. This phenotypic distribution within a single clonal complex makes CC8 an ideal clade to study the emergence of mutations important for antibiotic resistance and community spread. Gene level analysis comparing USA300 against MSSA and HA-MRSA strains have revealed key horizontally acquired genes important for its rapid spread in the community. However, efforts to define the contributions of point mutations and indels have been confounded by strong linkage disequilibrium resulting from clonal propagation. To break down this confounding effect, we combined genetic association testing with a model of the transcriptional regulatory network (TRN) to find candidate mutations that may have led to changes in gene regulation. First, we used a De Bruijn graph genome-wide association study (DBGWAS) to enrich mutations unique to the USA300 lineages within CC8. Next, we reconstructed the TRN by using Independent Component Analysis on 670 RNA sequencing samples from USA300 and non-USA300 CC8 strains which predicted several genes with strain-specific altered expression patterns. Examination of the regulatory region of one of the genes enriched by both approaches, isdH, revealed a 38 base pair deletion containing a Fur binding site and a conserved SNP which likely led to the altered expression levels in USA300 strains. Taken together, our results demonstrate the utility of reconstructed TRNs to address the limits of genetic approaches when studying emerging pathogenic strains.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.10.548371">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.10.548371" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.10.548371">
        <p class="paperTitle">Quantifying mutational synergy using computational models predicts survival in haematological cancers</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.10.548371" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.10.548371" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Norris, R.; Jones, J.; Mancini, E.; Chevassut, T.; Pepper, C.; Pepper, A.; Mitchell, S.</p>
        <p class="info">Score: 5.9, Published: 2023-07-11 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.10.548371' target='https://doi.org/10.1101/2023.07.10.548371'> 10.1101/2023.07.10.548371</a></p>
        <p class="abstract">Genetic heterogeneity and co-occurring driver mutations contribute to poor clinical outcomes in cancer. However, the impact of multiple mutations on complex signalling networks is not easily predicted. We found that, by placing mutations into their cellular context, multi-scale agent- based mathematical models could predict how genetic events combine in haematological malignancies. Simulations of lymphoma and myeloma predicted co-occurring mutations synergised to increase tumour cell expansion beyond what would be expected from the impact of the individual mutations alone. Mutational synergy between MYC and BCL2 was consistent with the more aggressive disease course of patients with double-hit lymphoma, and mutational synergy between MCL1 and CKS1B was predictive of outcome in patients with gain 1q multiple myeloma. Incorporating patient-specific mutational profiles into personalised models of lymphoma patients with the worst clinical outcomes revealed a correlation between simulated mutational synergy and overall survival, which outperformed widely used classifications of lymphoma informed by gene expression or mutational data alone. Our results demonstrated that mutational synergy scores enabled prediction of the impact of co-occurring mutations and may improve personalised prognostic predictions.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.08.03.551833">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.08.03.551833" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.08.03.551833">
        <p class="paperTitle">Evaluation of Fendiline Treatment in VP40 System with Nucleation-Elongation Process: A Computational Model of Ebola Virus Matrix Protein Assembly</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.08.03.551833" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.08.03.551833" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Liu, X.; Husby, M.; Stahelin, R. V.; Pienaar, E.</p>
        <p class="info">Score: 1.2, Published: 2023-08-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.08.03.551833' target='https://doi.org/10.1101/2023.08.03.551833'> 10.1101/2023.08.03.551833</a></p>
        <p class="abstract">Ebola virus (EBOV) infection is threatening human health, especially in Central and West Africa. Limited clinical trials and the requirement of biosafety level-4 (BSL-4) laboratories hinders experimental work to advance our understanding of EBOV and evaluation of treatment. In this work, we use a computational model to study the assembly and budding process of EBOV and evaluate the effect of fendiline on these processes. Our results indicate that the assembly of VP40 filaments may follow the nucleation-elongation theory, as it is critical to maintain a pool of VP40 dimer for the maturation and production of virus-like particles (VLPs). We further find that the nucleation-elongation process can also be influenced by phosphatidylserine (PS), which can complicate the efficacy of fendiline, a drug that lowers cellular PS levels. We observe that fendiline may increase VLP production at earlier time points (24 h) and under low concentrations ([&amp;le;] 2 M). But this effect is transient and does not change the conclusion that fendiline generally decreases VLP production. We also conclude that fendiline can be more efficient at the stage of VLP budding relative to earlier phases. Combination therapy with a VLP budding step-targeted drug may further increase the treatment efficiency of fendiline. Finally, we also show that fendiline has higher efficacy when VP40 expression is high. While these are single-cell level results based on the VP40 system, it points out a potential way of fendiline application affecting EBOV assembly, which can be further tested in experimental studies with multiple EBOV proteins or live virus.

ImportanceEBOV infection can cause deadly hemorrhagic fever, which has a mortality rate around 90% without treatment. The recent outbreaks in Uganda and Democratic Republic of the Congo illustrate its treat to human health. Though two antibody-based treatments are approved, mortality rates in the last outbreak is still higher than 30%. This can partly be due to the requirement of advanced medical facilities for current treatments. As a result, it is very important to develop and evaluate new therapies for EBOV infection, especially those can be easily applied in the developing world. The significance of our research is that we evaluate the potential treatment effect of fendiline on EBOV infection in the VP40 system with a computational approach, which both greatly saves time and lowers cost compared to traditional experimental studies, and provides innovative new tools to study viral protein dynamics.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.31.551116">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.31.551116" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.31.551116">
        <p class="paperTitle">Identifying repurposed drugs with moderate anti-influenza virus activity through computational prioritization of drug-target pairs</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.31.551116" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.31.551116" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Taye, B.; Thuenauer, R.; Sugrue, R. J.; Maurer-Stroh, S.; Kosinski, J.</p>
        <p class="info">Score: 1.2, Published: 2023-08-02 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.31.551116' target='https://doi.org/10.1101/2023.07.31.551116'> 10.1101/2023.07.31.551116</a></p>
        <p class="abstract">Influenza A virus (IAV) causes up to five million cases of severe illness and half a million deaths worldwide each year. While there are a few clinically approved drugs for treating IAV, they are challenged by the rapid evolution of the virus leading to emergence of drug resistance and the adverse effects of the drugs. Targeting host cellular factors that support virus replication could limit resistance, increase the broad-spectrum antiviral properties of drugs, and benefit from repurposing drugs already existing against those factors. However, selecting the right drug-target pairs with low toxicity and minimal adverse effects has been challenging, even though hundreds of cellular host factors have been identified. In this study, we applied a computational and knowledge-based drug-target prioritization approach to identify promising drug-target pairs. We selected five pairs for experimental validation: telmisartan-Angiotensin II receptor, type 1 (AGTR1), metoclopramide hydrochloride-Cholinergic receptor muscarinic 1 (CHRM1), cefepime hydrochloride-phosphogluconate dehydrogenase (PGD), ranolazine dihydrochloride-sodium channel voltage-gated type v alpha subunit (SCN5A), and ofloxacin-topoisomerase II alpha 170kDa (TOP2A). Except for cefepime hydrochloride, all four drugs showed significant plaque reduction in Madin Darby canine kidney (MDCK) cells. In the immunofluorescence assay, metoclopramide hydrochloride, ranolazine dihydrochloride, and telmisartan showed antiviral activity in MDCK and/or adenocarcinoma human alveolar basal epithelial (A549) cell lines. In conclusion, our approach can prioritize and identify drugs with antiviral activity against influenza virus. Refining and strengthening such approaches could be valuable for rapid antiviral discovery and pandemic preparedness.

HighlightsO_LIComputational drug-target prioritization indicated drugs for validation
C_LIO_LITelmisartan showed anti-influenza virus activity in MDCK cells
C_LIO_LIMetoclopramide and ranolazine showed anti-influenza activity in A549 and MDCK cells
C_LI</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.23.550214">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.23.550214" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.23.550214">
        <p class="paperTitle">Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.23.550214" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.23.550214" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Khoo, A.; Govindarajan, M.; Qui, Z.; Liu, L. Y.; Ignatchenko, V.; Waas, M.; Macklin, A.; Keszei, A.; Main, B. P.; Yang, L.; Lance, R. S.; Downes, M. R.; Semmes, O. J.; Vesprini, D.; Liu, S. K.; Nyalwidhe, J. O.; Boutros, P. C.; Kislinger, T.</p>
        <p class="info">Score: 9.5, Published: 2023-07-25 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.23.550214' target='https://doi.org/10.1101/2023.07.23.550214'> 10.1101/2023.07.23.550214</a></p>
        <p class="abstract">Urine is a complex biofluid that reflects both overall physiologic state and the state of the genitourinary tissues through which it passes. It contains both secreted proteins and proteins encapsulated in tissue-derived extracellular vesicles (EVs). To understand the population variability and clinical utility of urine, we quantified the secreted and EV proteomes from 190 men, including a subset with prostate cancer. We demonstrate that a simple protocol enriches prostatic proteins in urine. Secreted and EV proteins arise from different subcellular compartments. Urinary EVs are faithful surrogates of tissue proteomes, but secreted proteins in urine or cell line EVs are not. The urinary proteome is longitudinally stable over several years. It can accurately and non-invasively distinguish malignant from benign prostatic lesions, and can risk-stratify prostate tumors. This resource quantifies the complexity of the urinary proteome, and reveals the synergistic value of secreted and EV proteomes for translational and biomarker studies.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
         Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
